查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1857079

皮質類固醇原料藥：全球市佔率排名、總銷售額與需求預測（2025-2031年）

Corticosteroids API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年全球皮質類固醇原料藥市場規模估計為 24.21 億美元，預計到 2031 年將達到 36.45 億美元，在 2025-2031 年預測期內複合年成長率為 6.1%。

皮質類固醇活性藥物原料藥（API）是生產皮質類固醇藥物的主要原料，這些藥物因其抗發炎、免疫抑制和抗過敏特性而被廣泛應用。這些API包括Hydrocortisone、潑尼松龍、地塞米松和Betamethasone等化合物，是治療氣喘、類風濕性關節炎、皮膚病、自體免疫疾病等疾病的必需藥物。皮質類固醇API的生產需要複雜的化學合成和嚴格的品管，以確保其高純度、高效力並符合包括美國FDA、歐盟EMA和中國國家藥品監督管理局（NMPA）在內的監管標準。隨著對皮質類固醇類藥物治療需求的持續成長，皮質類固醇原料藥市場仍然是製藥業的重要組成部分，尤其是在皮膚病學、呼吸系統疾病和器官移植領域。

近年來，受製藥業需求的推動，皮質類固醇原料藥市場保持穩定成長。作為廣泛用於治療發炎、免疫抑制、皮膚病和呼吸系統疾病的關鍵成分，皮質類固醇原料藥在全球持續受到青睞。人口老化、慢性病增加以及醫療保健體系的改善等因素，都促使市場對高品質原料藥的需求不斷成長。此外，學名藥產業的擴張也推動了市場成長，而政策支援和本地原料藥能力的提升，尤其是在新興國家，也進一步增強了市場需求。

展望未來，皮質類固醇原料藥市場預計將呈現幾個關鍵趨勢。首先，日益嚴格的環境法規推動了對更環保、更合規的生產流程的需求，促使企業加強研發投入，以減少排放並提高生產效率。其次，隨著市場競爭加劇，一些高階皮質類固醇產品將在專利到期後轉型為更高價值的學名藥，從而實現差異化策略。此外，供應鏈在地化趨勢日益顯著，部分國家正在加強國內原料藥供給能力以降低進口依賴，這將影響全球市場格局。同時，生物技術的進步正在引入新的合成路線和替代療法，這可能會對傳統的皮質類固醇原料藥市場構成挑戰。

關鍵成長促進因素包括不斷成長的醫療需求、全球製藥業的擴張以及政策支持，尤其是在新興市場，這些國家的政府鼓勵本地生產並提供稅收優惠。此外，生產技術的進步、製劑創新和新適應症的出現也創造了新的成長機會。然而，該行業面臨許多挑戰，例如原料價格波動、環境合規成本上升以及主要生產商之間的激烈競爭。更嚴格的全球監管政策提高了合規要求，並可能迫使一些公司退出市場。此外，學名藥領域日益激烈的競爭也給原料藥的價格帶來了壓力，從而影響了整體盈利。

本報告旨在全面概述全球皮質類固醇原料藥市場，重點關注總銷售量、銷售收入、價格、市場佔有率和主要企業的排名，並按地區/國家、類型和應用分析皮質類固醇原料藥。

本報告以銷售量（噸）和銷售收入（百萬美元）為單位，提供皮質類固醇原料藥市場規模、估算和預測，以2024年為基準年，並包含2020年至2031年的歷史數據和預測數據。定量和定性分析有助於讀者制定業務/成長策略、評估競爭格局、分析公司在當前市場中的地位，並就皮質類固醇原料藥做出明智的商業決策。

目錄

第1章 市場概覽

  • 皮質類腎上腺皮質荷爾蒙原料藥產品介紹
  • 全球皮質類固醇原料藥市場規模預測
  • 皮質類固醇原料藥市場趨勢及促進因素
  • 前提條件和限制條件
  • 調查目的
  • 多年的考慮

第2章 公司競爭分析

  • 全球皮質類固醇原料藥公司營收排名（2024 年）
  • 全球皮質類固醇原料藥收入（按公司分類）（2020-2025 年）
  • 全球皮質類固醇原料藥公司銷售額排名（2024 年）
  • 全球皮質類固醇原料藥銷售額（按公司分列）（2020-2025 年）
  • 全球皮質類固醇原料藥平均價格（按公司分類）（2020-2025 年）
  • 主要皮質類固醇原料藥生產商的製造地和總部
  • 領先製造商提供的皮質類固醇原料藥產品
  • 大型生產者何時開始大規模生產皮質類固醇原料藥？
  • 皮質類固醇原料藥市場競爭分析
  • 併購、擴張

第3章 依類型細分

  • 按類型介紹
    • 潑尼松系列
    • 地塞米松系列
    • Betamethasone系列
    • Hydrocortisone系列
    • 其他
  • 全球皮質類固醇原料藥銷售額（按類型分類）
  • 全球皮質類固醇原料藥銷售（按類型分類）
  • 全球皮質類固醇原料藥平均價格（按類型分類）（2020-2031 年）

第4章 按應用進行細分

  • 透過申請
    • 注射
    • 口服藥物
    • 外用藥物
    • 吸入藥物
  • 全球皮質類固醇原料藥銷售額（按應用領域分類）
  • 全球皮質類固醇原料藥銷售額（按應用領域分類）
  • 全球皮質類固醇原料藥平均價格（按應用領域分類）（2020-2031 年）

第5章 區域細分

  • 全球皮質類固醇原料藥銷售額（按地區分類）
  • 全球皮質類固醇原料藥銷售額（按地區分類）
  • 全球皮質類固醇原料藥平均價格（按地區分類）（2020-2031 年）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第6章 按主要國家分類

  • 主要國家/地區皮質類固醇原料藥銷售額成長趨勢，2020 年、2024 年和 2031 年對比
  • 主要國家/地區皮質類固醇原料藥銷售額及銷售
  • 美國
  • 歐洲
  • 中國
  • 日本
  • 韓國
  • 東南亞
  • 印度

第7章 公司簡介

  • Pfizer CentreOne
  • EUROAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid SpA
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Cipla
  • Wellona Pharma
  • Tianjin Tianyao Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical
  • Guangdong VTR BioTech
  • Zhejiang Xianju Xianle Pharmaceutical
  • Tianjin Pacific Pharmaceutical
  • Shandong Xinhua Pharmaceutica Group
  • Jiangsu Lianhuan Pharmaceutical
  • Shanghai New Hualian Pharmaceutical
  • Shandong Taihua Biotech
  • Shandong Sito Bio-technology
  • Zhejiang Xianju Junye Pharmaceutical

第8章：產業鏈分析

第9章 研究結果與結論

第10章附錄

The global market for Corticosteroids API was estimated to be worth US$ 2421 million in 2024 and is forecast to a readjusted size of US$ 3645 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

Corticosteroids Active Pharmaceutical Ingredients (APIs) are key raw materials used in the production of corticosteroid medications, which are widely utilized for their anti-inflammatory, immunosuppressive, and anti-allergic properties. These APIs include compounds such as hydrocortisone, prednisolone, dexamethasone, and betamethasone, which are essential in the treatment of conditions like asthma, rheumatoid arthritis, skin disorders, and autoimmune diseases. The production of corticosteroid APIs involves complex chemical synthesis and stringent quality control to ensure high purity, efficacy, and compliance with regulatory standards such as those set by the US FDA, EU EMA, and China NMPA. As demand for corticosteroid-based treatments continues to grow, particularly in dermatology, respiratory diseases, and organ transplantation, the corticosteroid API market remains a crucial segment within the pharmaceutical industry.

The corticosteroids API market has maintained stable growth in recent years, driven primarily by the pharmaceutical industry's demand. As a key component widely used in the treatment of inflammation, immunosuppression, dermatological conditions, and respiratory diseases, corticosteroids APIs continue to be in demand globally. Factors such as an aging population, rising prevalence of chronic diseases, and improvements in healthcare systems contribute to the increasing need for high-quality APIs. Additionally, the expansion of the generic drug industry has fueled market growth, particularly in emerging economies where policy support and the enhancement of local pharmaceutical capabilities are strengthening demand.

Looking ahead, the corticosteroids API market is expected to follow several key trends. Firstly, stricter environmental regulations are driving the need for greener and more compliant manufacturing processes, pushing companies to invest in R&D to reduce emissions and improve production efficiency. Secondly, as market competition intensifies, some high-end corticosteroid products will shift toward high-value generics following patent expirations, enabling differentiation strategies. Additionally, supply chain localization is becoming more prominent, with certain countries and regions strengthening their domestic API supply capabilities to reduce import dependency, impacting the global market structure. Furthermore, advancements in biotechnology may introduce new synthetic pathways and alternative therapies that could pose a challenge to the traditional corticosteroids API market.

Key growth drivers include rising medical demand, expansion of the global pharmaceutical industry, and policy support, particularly in emerging markets where governments encourage local production and offer tax incentives. Additionally, advancements in production technology, formulation innovations, and new indications are creating new growth opportunities. However, the industry faces challenges such as fluctuations in raw material prices, rising environmental compliance costs, and intense competition among leading manufacturers. Stricter global regulatory policies impose higher compliance requirements, potentially driving some companies out of the market. Moreover, increasing competition in the generics sector is putting pricing pressure on APIs, affecting overall profitability.

This report aims to provide a comprehensive presentation of the global market for Corticosteroids API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Corticosteroids API by region & country, by Type, and by Application.

The Corticosteroids API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Corticosteroids API.

Market Segmentation

By Company

  • Pfizer CentreOne
  • EUROAPI
  • GlaxoSmithKline
  • Teva Pharmaceutical Industries
  • Hovione
  • Axplora
  • Steroid SpA
  • Avik Pharmaceutical
  • Anuh Pharma
  • Symbiotec Pharmalab
  • Sun Pharmaceutical
  • Cipla
  • Wellona Pharma
  • Tianjin Tianyao Pharmaceuticals
  • Zhejiang Xianju Pharmaceutical
  • Guangdong VTR BioTech
  • Zhejiang Xianju Xianle Pharmaceutical
  • Tianjin Pacific Pharmaceutical
  • Shandong Xinhua Pharmaceutica Group
  • Jiangsu Lianhuan Pharmaceutical
  • Shanghai New Hualian Pharmaceutical
  • Shandong Taihua Biotech
  • Shandong Sito Bio-technology
  • Zhejiang Xianju Junye Pharmaceutical

Segment by Type

  • Prednisone Series
  • Dexamethasone Series
  • Betamethasone Series
  • Hydrocortisone Series
  • Others

Segment by Application

  • Injectable Drugs
  • Oral Drugs
  • Topical Drugs
  • Inhaled Drugs

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Corticosteroids API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Corticosteroids API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Corticosteroids API in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Corticosteroids API Product Introduction
  • 1.2 Global Corticosteroids API Market Size Forecast
    • 1.2.1 Global Corticosteroids API Sales Value (2020-2031)
    • 1.2.2 Global Corticosteroids API Sales Volume (2020-2031)
    • 1.2.3 Global Corticosteroids API Sales Price (2020-2031)
  • 1.3 Corticosteroids API Market Trends & Drivers
    • 1.3.1 Corticosteroids API Industry Trends
    • 1.3.2 Corticosteroids API Market Drivers & Opportunity
    • 1.3.3 Corticosteroids API Market Challenges
    • 1.3.4 Corticosteroids API Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Corticosteroids API Players Revenue Ranking (2024)
  • 2.2 Global Corticosteroids API Revenue by Company (2020-2025)
  • 2.3 Global Corticosteroids API Players Sales Volume Ranking (2024)
  • 2.4 Global Corticosteroids API Sales Volume by Company Players (2020-2025)
  • 2.5 Global Corticosteroids API Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Corticosteroids API Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Corticosteroids API Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Corticosteroids API
  • 2.9 Corticosteroids API Market Competitive Analysis
    • 2.9.1 Corticosteroids API Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Corticosteroids API Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroids API as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Prednisone Series
    • 3.1.2 Dexamethasone Series
    • 3.1.3 Betamethasone Series
    • 3.1.4 Hydrocortisone Series
    • 3.1.5 Others
  • 3.2 Global Corticosteroids API Sales Value by Type
    • 3.2.1 Global Corticosteroids API Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Corticosteroids API Sales Value, by Type (2020-2031)
    • 3.2.3 Global Corticosteroids API Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Corticosteroids API Sales Volume by Type
    • 3.3.1 Global Corticosteroids API Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Corticosteroids API Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Corticosteroids API Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Corticosteroids API Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Injectable Drugs
    • 4.1.2 Oral Drugs
    • 4.1.3 Topical Drugs
    • 4.1.4 Inhaled Drugs
  • 4.2 Global Corticosteroids API Sales Value by Application
    • 4.2.1 Global Corticosteroids API Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Corticosteroids API Sales Value, by Application (2020-2031)
    • 4.2.3 Global Corticosteroids API Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Corticosteroids API Sales Volume by Application
    • 4.3.1 Global Corticosteroids API Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Corticosteroids API Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Corticosteroids API Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Corticosteroids API Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Corticosteroids API Sales Value by Region
    • 5.1.1 Global Corticosteroids API Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Corticosteroids API Sales Value by Region (2020-2025)
    • 5.1.3 Global Corticosteroids API Sales Value by Region (2026-2031)
    • 5.1.4 Global Corticosteroids API Sales Value by Region (%), (2020-2031)
  • 5.2 Global Corticosteroids API Sales Volume by Region
    • 5.2.1 Global Corticosteroids API Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Corticosteroids API Sales Volume by Region (2020-2025)
    • 5.2.3 Global Corticosteroids API Sales Volume by Region (2026-2031)
    • 5.2.4 Global Corticosteroids API Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Corticosteroids API Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Corticosteroids API Sales Value, 2020-2031
    • 5.4.2 North America Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Corticosteroids API Sales Value, 2020-2031
    • 5.5.2 Europe Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Corticosteroids API Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Corticosteroids API Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Corticosteroids API Sales Value, 2020-2031
    • 5.7.2 South America Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Corticosteroids API Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Corticosteroids API Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Corticosteroids API Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Corticosteroids API Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Corticosteroids API Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Corticosteroids API Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Corticosteroids API Sales Value, 2020-2031
    • 6.3.2 United States Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Corticosteroids API Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Corticosteroids API Sales Value, 2020-2031
    • 6.4.2 Europe Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Corticosteroids API Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Corticosteroids API Sales Value, 2020-2031
    • 6.5.2 China Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Corticosteroids API Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Corticosteroids API Sales Value, 2020-2031
    • 6.6.2 Japan Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Corticosteroids API Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Corticosteroids API Sales Value, 2020-2031
    • 6.7.2 South Korea Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Corticosteroids API Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Corticosteroids API Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Corticosteroids API Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Corticosteroids API Sales Value, 2020-2031
    • 6.9.2 India Corticosteroids API Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Corticosteroids API Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Pfizer CentreOne
    • 7.1.1 Pfizer CentreOne Company Information
    • 7.1.2 Pfizer CentreOne Introduction and Business Overview
    • 7.1.3 Pfizer CentreOne Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Pfizer CentreOne Corticosteroids API Product Offerings
    • 7.1.5 Pfizer CentreOne Recent Development
  • 7.2 EUROAPI
    • 7.2.1 EUROAPI Company Information
    • 7.2.2 EUROAPI Introduction and Business Overview
    • 7.2.3 EUROAPI Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 EUROAPI Corticosteroids API Product Offerings
    • 7.2.5 EUROAPI Recent Development
  • 7.3 GlaxoSmithKline
    • 7.3.1 GlaxoSmithKline Company Information
    • 7.3.2 GlaxoSmithKline Introduction and Business Overview
    • 7.3.3 GlaxoSmithKline Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 GlaxoSmithKline Corticosteroids API Product Offerings
    • 7.3.5 GlaxoSmithKline Recent Development
  • 7.4 Teva Pharmaceutical Industries
    • 7.4.1 Teva Pharmaceutical Industries Company Information
    • 7.4.2 Teva Pharmaceutical Industries Introduction and Business Overview
    • 7.4.3 Teva Pharmaceutical Industries Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Teva Pharmaceutical Industries Corticosteroids API Product Offerings
    • 7.4.5 Teva Pharmaceutical Industries Recent Development
  • 7.5 Hovione
    • 7.5.1 Hovione Company Information
    • 7.5.2 Hovione Introduction and Business Overview
    • 7.5.3 Hovione Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hovione Corticosteroids API Product Offerings
    • 7.5.5 Hovione Recent Development
  • 7.6 Axplora
    • 7.6.1 Axplora Company Information
    • 7.6.2 Axplora Introduction and Business Overview
    • 7.6.3 Axplora Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Axplora Corticosteroids API Product Offerings
    • 7.6.5 Axplora Recent Development
  • 7.7 Steroid SpA
    • 7.7.1 Steroid SpA Company Information
    • 7.7.2 Steroid SpA Introduction and Business Overview
    • 7.7.3 Steroid SpA Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Steroid SpA Corticosteroids API Product Offerings
    • 7.7.5 Steroid SpA Recent Development
  • 7.8 Avik Pharmaceutical
    • 7.8.1 Avik Pharmaceutical Company Information
    • 7.8.2 Avik Pharmaceutical Introduction and Business Overview
    • 7.8.3 Avik Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Avik Pharmaceutical Corticosteroids API Product Offerings
    • 7.8.5 Avik Pharmaceutical Recent Development
  • 7.9 Anuh Pharma
    • 7.9.1 Anuh Pharma Company Information
    • 7.9.2 Anuh Pharma Introduction and Business Overview
    • 7.9.3 Anuh Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Anuh Pharma Corticosteroids API Product Offerings
    • 7.9.5 Anuh Pharma Recent Development
  • 7.10 Symbiotec Pharmalab
    • 7.10.1 Symbiotec Pharmalab Company Information
    • 7.10.2 Symbiotec Pharmalab Introduction and Business Overview
    • 7.10.3 Symbiotec Pharmalab Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 Symbiotec Pharmalab Corticosteroids API Product Offerings
    • 7.10.5 Symbiotec Pharmalab Recent Development
  • 7.11 Sun Pharmaceutical
    • 7.11.1 Sun Pharmaceutical Company Information
    • 7.11.2 Sun Pharmaceutical Introduction and Business Overview
    • 7.11.3 Sun Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 Sun Pharmaceutical Corticosteroids API Product Offerings
    • 7.11.5 Sun Pharmaceutical Recent Development
  • 7.12 Cipla
    • 7.12.1 Cipla Company Information
    • 7.12.2 Cipla Introduction and Business Overview
    • 7.12.3 Cipla Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Cipla Corticosteroids API Product Offerings
    • 7.12.5 Cipla Recent Development
  • 7.13 Wellona Pharma
    • 7.13.1 Wellona Pharma Company Information
    • 7.13.2 Wellona Pharma Introduction and Business Overview
    • 7.13.3 Wellona Pharma Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.13.4 Wellona Pharma Corticosteroids API Product Offerings
    • 7.13.5 Wellona Pharma Recent Development
  • 7.14 Tianjin Tianyao Pharmaceuticals
    • 7.14.1 Tianjin Tianyao Pharmaceuticals Company Information
    • 7.14.2 Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
    • 7.14.3 Tianjin Tianyao Pharmaceuticals Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.14.4 Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Offerings
    • 7.14.5 Tianjin Tianyao Pharmaceuticals Recent Development
  • 7.15 Zhejiang Xianju Pharmaceutical
    • 7.15.1 Zhejiang Xianju Pharmaceutical Company Information
    • 7.15.2 Zhejiang Xianju Pharmaceutical Introduction and Business Overview
    • 7.15.3 Zhejiang Xianju Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.15.4 Zhejiang Xianju Pharmaceutical Corticosteroids API Product Offerings
    • 7.15.5 Zhejiang Xianju Pharmaceutical Recent Development
  • 7.16 Guangdong VTR BioTech
    • 7.16.1 Guangdong VTR BioTech Company Information
    • 7.16.2 Guangdong VTR BioTech Introduction and Business Overview
    • 7.16.3 Guangdong VTR BioTech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.16.4 Guangdong VTR BioTech Corticosteroids API Product Offerings
    • 7.16.5 Guangdong VTR BioTech Recent Development
  • 7.17 Zhejiang Xianju Xianle Pharmaceutical
    • 7.17.1 Zhejiang Xianju Xianle Pharmaceutical Company Information
    • 7.17.2 Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
    • 7.17.3 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.17.4 Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Offerings
    • 7.17.5 Zhejiang Xianju Xianle Pharmaceutical Recent Development
  • 7.18 Tianjin Pacific Pharmaceutical
    • 7.18.1 Tianjin Pacific Pharmaceutical Company Information
    • 7.18.2 Tianjin Pacific Pharmaceutical Introduction and Business Overview
    • 7.18.3 Tianjin Pacific Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.18.4 Tianjin Pacific Pharmaceutical Corticosteroids API Product Offerings
    • 7.18.5 Tianjin Pacific Pharmaceutical Recent Development
  • 7.19 Shandong Xinhua Pharmaceutica Group
    • 7.19.1 Shandong Xinhua Pharmaceutica Group Company Information
    • 7.19.2 Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
    • 7.19.3 Shandong Xinhua Pharmaceutica Group Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.19.4 Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Offerings
    • 7.19.5 Shandong Xinhua Pharmaceutica Group Recent Development
  • 7.20 Jiangsu Lianhuan Pharmaceutical
    • 7.20.1 Jiangsu Lianhuan Pharmaceutical Company Information
    • 7.20.2 Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
    • 7.20.3 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.20.4 Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Offerings
    • 7.20.5 Jiangsu Lianhuan Pharmaceutical Recent Development
  • 7.21 Shanghai New Hualian Pharmaceutical
    • 7.21.1 Shanghai New Hualian Pharmaceutical Company Information
    • 7.21.2 Shanghai New Hualian Pharmaceutical Introduction and Business Overview
    • 7.21.3 Shanghai New Hualian Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.21.4 Shanghai New Hualian Pharmaceutical Corticosteroids API Product Offerings
    • 7.21.5 Shanghai New Hualian Pharmaceutical Recent Development
  • 7.22 Shandong Taihua Biotech
    • 7.22.1 Shandong Taihua Biotech Company Information
    • 7.22.2 Shandong Taihua Biotech Introduction and Business Overview
    • 7.22.3 Shandong Taihua Biotech Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.22.4 Shandong Taihua Biotech Corticosteroids API Product Offerings
    • 7.22.5 Shandong Taihua Biotech Recent Development
  • 7.23 Shandong Sito Bio-technology
    • 7.23.1 Shandong Sito Bio-technology Company Information
    • 7.23.2 Shandong Sito Bio-technology Introduction and Business Overview
    • 7.23.3 Shandong Sito Bio-technology Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.23.4 Shandong Sito Bio-technology Corticosteroids API Product Offerings
    • 7.23.5 Shandong Sito Bio-technology Recent Development
  • 7.24 Zhejiang Xianju Junye Pharmaceutical
    • 7.24.1 Zhejiang Xianju Junye Pharmaceutical Company Information
    • 7.24.2 Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
    • 7.24.3 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.24.4 Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Offerings
    • 7.24.5 Zhejiang Xianju Junye Pharmaceutical Recent Development

8 Industry Chain Analysis

  • 8.1 Corticosteroids API Industrial Chain
  • 8.2 Corticosteroids API Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Corticosteroids API Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Corticosteroids API Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Corticosteroids API Market Trends
  • Table 2. Corticosteroids API Market Drivers & Opportunity
  • Table 3. Corticosteroids API Market Challenges
  • Table 4. Corticosteroids API Market Restraints
  • Table 5. Global Corticosteroids API Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Corticosteroids API Revenue Market Share by Company (2020-2025)
  • Table 7. Global Corticosteroids API Sales Volume by Company (2020-2025) & (Tons)
  • Table 8. Global Corticosteroids API Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Corticosteroids API Price by Company (2020-2025) & (US$/kg)
  • Table 10. Key Manufacturers Corticosteroids API Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Corticosteroids API Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Corticosteroids API
  • Table 13. Global Corticosteroids API Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Corticosteroids API as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Corticosteroids API Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Corticosteroids API Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Corticosteroids API Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Corticosteroids API Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Corticosteroids API Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Corticosteroids API Sales Volume by Type: 2020 VS 2024 VS 2031 (Tons)
  • Table 22. Global Corticosteroids API Sales Volume by Type (2020-2025) & (Tons)
  • Table 23. Global Corticosteroids API Sales Volume by Type (2026-2031) & (Tons)
  • Table 24. Global Corticosteroids API Sales Volume Market Share by Type (2020-2025)
  • Table 25. Global Corticosteroids API Sales Volume Market Share by Type (2026-2031)
  • Table 26. Global Corticosteroids API Price by Type (2020-2025) & (US$/kg)
  • Table 27. Global Corticosteroids API Price by Type (2026-2031) & (US$/kg)
  • Table 28. Global Corticosteroids API Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Corticosteroids API Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Corticosteroids API Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Corticosteroids API Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Corticosteroids API Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Corticosteroids API Sales Volume by Application: 2020 VS 2024 VS 2031 (Tons)
  • Table 34. Global Corticosteroids API Sales Volume by Application (2020-2025) & (Tons)
  • Table 35. Global Corticosteroids API Sales Volume by Application (2026-2031) & (Tons)
  • Table 36. Global Corticosteroids API Sales Volume Market Share by Application (2020-2025)
  • Table 37. Global Corticosteroids API Sales Volume Market Share by Application (2026-2031)
  • Table 38. Global Corticosteroids API Price by Application (2020-2025) & (US$/kg)
  • Table 39. Global Corticosteroids API Price by Application (2026-2031) & (US$/kg)
  • Table 40. Global Corticosteroids API Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Corticosteroids API Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Corticosteroids API Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Corticosteroids API Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Corticosteroids API Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Corticosteroids API Sales Volume by Region (Tons): 2020 VS 2024 VS 2031
  • Table 46. Global Corticosteroids API Sales Volume by Region (2020-2025) & (Tons)
  • Table 47. Global Corticosteroids API Sales Volume by Region (2026-2031) & (Tons)
  • Table 48. Global Corticosteroids API Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Corticosteroids API Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Corticosteroids API Average Price by Region (2020-2025) & (US$/kg)
  • Table 51. Global Corticosteroids API Average Price by Region (2026-2031) & (US$/kg)
  • Table 52. Key Countries/Regions Corticosteroids API Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Corticosteroids API Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Corticosteroids API Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Corticosteroids API Sales Volume, (2020-2025) & (Tons)
  • Table 56. Key Countries/Regions Corticosteroids API Sales Volume, (2026-2031) & (Tons)
  • Table 57. Pfizer CentreOne Company Information
  • Table 58. Pfizer CentreOne Introduction and Business Overview
  • Table 59. Pfizer CentreOne Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 60. Pfizer CentreOne Corticosteroids API Product Offerings
  • Table 61. Pfizer CentreOne Recent Development
  • Table 62. EUROAPI Company Information
  • Table 63. EUROAPI Introduction and Business Overview
  • Table 64. EUROAPI Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 65. EUROAPI Corticosteroids API Product Offerings
  • Table 66. EUROAPI Recent Development
  • Table 67. GlaxoSmithKline Company Information
  • Table 68. GlaxoSmithKline Introduction and Business Overview
  • Table 69. GlaxoSmithKline Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 70. GlaxoSmithKline Corticosteroids API Product Offerings
  • Table 71. GlaxoSmithKline Recent Development
  • Table 72. Teva Pharmaceutical Industries Company Information
  • Table 73. Teva Pharmaceutical Industries Introduction and Business Overview
  • Table 74. Teva Pharmaceutical Industries Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 75. Teva Pharmaceutical Industries Corticosteroids API Product Offerings
  • Table 76. Teva Pharmaceutical Industries Recent Development
  • Table 77. Hovione Company Information
  • Table 78. Hovione Introduction and Business Overview
  • Table 79. Hovione Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 80. Hovione Corticosteroids API Product Offerings
  • Table 81. Hovione Recent Development
  • Table 82. Axplora Company Information
  • Table 83. Axplora Introduction and Business Overview
  • Table 84. Axplora Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 85. Axplora Corticosteroids API Product Offerings
  • Table 86. Axplora Recent Development
  • Table 87. Steroid SpA Company Information
  • Table 88. Steroid SpA Introduction and Business Overview
  • Table 89. Steroid SpA Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 90. Steroid SpA Corticosteroids API Product Offerings
  • Table 91. Steroid SpA Recent Development
  • Table 92. Avik Pharmaceutical Company Information
  • Table 93. Avik Pharmaceutical Introduction and Business Overview
  • Table 94. Avik Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 95. Avik Pharmaceutical Corticosteroids API Product Offerings
  • Table 96. Avik Pharmaceutical Recent Development
  • Table 97. Anuh Pharma Company Information
  • Table 98. Anuh Pharma Introduction and Business Overview
  • Table 99. Anuh Pharma Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 100. Anuh Pharma Corticosteroids API Product Offerings
  • Table 101. Anuh Pharma Recent Development
  • Table 102. Symbiotec Pharmalab Company Information
  • Table 103. Symbiotec Pharmalab Introduction and Business Overview
  • Table 104. Symbiotec Pharmalab Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 105. Symbiotec Pharmalab Corticosteroids API Product Offerings
  • Table 106. Symbiotec Pharmalab Recent Development
  • Table 107. Sun Pharmaceutical Company Information
  • Table 108. Sun Pharmaceutical Introduction and Business Overview
  • Table 109. Sun Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 110. Sun Pharmaceutical Corticosteroids API Product Offerings
  • Table 111. Sun Pharmaceutical Recent Development
  • Table 112. Cipla Company Information
  • Table 113. Cipla Introduction and Business Overview
  • Table 114. Cipla Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 115. Cipla Corticosteroids API Product Offerings
  • Table 116. Cipla Recent Development
  • Table 117. Wellona Pharma Company Information
  • Table 118. Wellona Pharma Introduction and Business Overview
  • Table 119. Wellona Pharma Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 120. Wellona Pharma Corticosteroids API Product Offerings
  • Table 121. Wellona Pharma Recent Development
  • Table 122. Tianjin Tianyao Pharmaceuticals Company Information
  • Table 123. Tianjin Tianyao Pharmaceuticals Introduction and Business Overview
  • Table 124. Tianjin Tianyao Pharmaceuticals Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 125. Tianjin Tianyao Pharmaceuticals Corticosteroids API Product Offerings
  • Table 126. Tianjin Tianyao Pharmaceuticals Recent Development
  • Table 127. Zhejiang Xianju Pharmaceutical Company Information
  • Table 128. Zhejiang Xianju Pharmaceutical Introduction and Business Overview
  • Table 129. Zhejiang Xianju Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 130. Zhejiang Xianju Pharmaceutical Corticosteroids API Product Offerings
  • Table 131. Zhejiang Xianju Pharmaceutical Recent Development
  • Table 132. Guangdong VTR BioTech Company Information
  • Table 133. Guangdong VTR BioTech Introduction and Business Overview
  • Table 134. Guangdong VTR BioTech Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 135. Guangdong VTR BioTech Corticosteroids API Product Offerings
  • Table 136. Guangdong VTR BioTech Recent Development
  • Table 137. Zhejiang Xianju Xianle Pharmaceutical Company Information
  • Table 138. Zhejiang Xianju Xianle Pharmaceutical Introduction and Business Overview
  • Table 139. Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 140. Zhejiang Xianju Xianle Pharmaceutical Corticosteroids API Product Offerings
  • Table 141. Zhejiang Xianju Xianle Pharmaceutical Recent Development
  • Table 142. Tianjin Pacific Pharmaceutical Company Information
  • Table 143. Tianjin Pacific Pharmaceutical Introduction and Business Overview
  • Table 144. Tianjin Pacific Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 145. Tianjin Pacific Pharmaceutical Corticosteroids API Product Offerings
  • Table 146. Tianjin Pacific Pharmaceutical Recent Development
  • Table 147. Shandong Xinhua Pharmaceutica Group Company Information
  • Table 148. Shandong Xinhua Pharmaceutica Group Introduction and Business Overview
  • Table 149. Shandong Xinhua Pharmaceutica Group Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 150. Shandong Xinhua Pharmaceutica Group Corticosteroids API Product Offerings
  • Table 151. Shandong Xinhua Pharmaceutica Group Recent Development
  • Table 152. Jiangsu Lianhuan Pharmaceutical Company Information
  • Table 153. Jiangsu Lianhuan Pharmaceutical Introduction and Business Overview
  • Table 154. Jiangsu Lianhuan Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 155. Jiangsu Lianhuan Pharmaceutical Corticosteroids API Product Offerings
  • Table 156. Jiangsu Lianhuan Pharmaceutical Recent Development
  • Table 157. Shanghai New Hualian Pharmaceutical Company Information
  • Table 158. Shanghai New Hualian Pharmaceutical Introduction and Business Overview
  • Table 159. Shanghai New Hualian Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 160. Shanghai New Hualian Pharmaceutical Corticosteroids API Product Offerings
  • Table 161. Shanghai New Hualian Pharmaceutical Recent Development
  • Table 162. Shandong Taihua Biotech Company Information
  • Table 163. Shandong Taihua Biotech Introduction and Business Overview
  • Table 164. Shandong Taihua Biotech Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 165. Shandong Taihua Biotech Corticosteroids API Product Offerings
  • Table 166. Shandong Taihua Biotech Recent Development
  • Table 167. Shandong Sito Bio-technology Company Information
  • Table 168. Shandong Sito Bio-technology Introduction and Business Overview
  • Table 169. Shandong Sito Bio-technology Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 170. Shandong Sito Bio-technology Corticosteroids API Product Offerings
  • Table 171. Shandong Sito Bio-technology Recent Development
  • Table 172. Zhejiang Xianju Junye Pharmaceutical Company Information
  • Table 173. Zhejiang Xianju Junye Pharmaceutical Introduction and Business Overview
  • Table 174. Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
  • Table 175. Zhejiang Xianju Junye Pharmaceutical Corticosteroids API Product Offerings
  • Table 176. Zhejiang Xianju Junye Pharmaceutical Recent Development
  • Table 177. Key Raw Materials Lists
  • Table 178. Raw Materials Key Suppliers Lists
  • Table 179. Corticosteroids API Downstream Customers
  • Table 180. Corticosteroids API Distributors List
  • Table 181. Research Programs/Design for This Report
  • Table 182. Key Data Information from Secondary Sources
  • Table 183. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Corticosteroids API Product Picture
  • Figure 2. Global Corticosteroids API Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Corticosteroids API Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Corticosteroids API Sales Volume (2020-2031) & (Tons)
  • Figure 5. Global Corticosteroids API Sales Price (2020-2031) & (US$/kg)
  • Figure 6. Corticosteroids API Report Years Considered
  • Figure 7. Global Corticosteroids API Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Corticosteroids API Players Sales Volume Ranking (2024) & (Tons)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Corticosteroids API Revenue in 2024
  • Figure 10. Corticosteroids API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Prednisone Series Picture
  • Figure 12. Dexamethasone Series Picture
  • Figure 13. Betamethasone Series Picture
  • Figure 14. Hydrocortisone Series Picture
  • Figure 15. Others Picture
  • Figure 16. Global Corticosteroids API Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 17. Global Corticosteroids API Sales Value Market Share by Type, 2024 & 2031
  • Figure 18. Global Corticosteroids API Sales Volume by Type (2020 VS 2024 VS 2031) & (Tons)
  • Figure 19. Global Corticosteroids API Sales Volume Market Share by Type, 2024 & 2031
  • Figure 20. Global Corticosteroids API Price by Type (2020-2031) & (US$/kg)
  • Figure 21. Product Picture of Injectable Drugs
  • Figure 22. Product Picture of Oral Drugs
  • Figure 23. Product Picture of Topical Drugs
  • Figure 24. Product Picture of Inhaled Drugs
  • Figure 25. Global Corticosteroids API Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 26. Global Corticosteroids API Sales Value Market Share by Application, 2024 & 2031
  • Figure 27. Global Corticosteroids API Sales Volume by Application (2020 VS 2024 VS 2031) & (Tons)
  • Figure 28. Global Corticosteroids API Sales Volume Market Share by Application, 2024 & 2031
  • Figure 29. Global Corticosteroids API Price by Application (2020-2031) & (US$/kg)
  • Figure 30. North America Corticosteroids API Sales Value (2020-2031) & (US$ Million)
  • Figure 31. North America Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • Figure 32. Europe Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. Europe Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Asia Pacific Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Asia Pacific Corticosteroids API Sales Value by Region (%), 2024 VS 2031
  • Figure 36. South America Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 37. South America Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • Figure 38. Middle East & Africa Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. Middle East & Africa Corticosteroids API Sales Value by Country (%), 2024 VS 2031
  • Figure 40. Key Countries/Regions Corticosteroids API Sales Value (%), (2020-2031)
  • Figure 41. Key Countries/Regions Corticosteroids API Sales Volume (%), (2020-2031)
  • Figure 42. United States Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 43. United States Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 44. United States Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 45. Europe Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 46. Europe Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 47. Europe Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 48. China Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 49. China Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 50. China Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 51. Japan Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 52. Japan Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 53. Japan Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 54. South Korea Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 55. South Korea Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 56. South Korea Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 57. Southeast Asia Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 58. Southeast Asia Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 59. Southeast Asia Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 60. India Corticosteroids API Sales Value, (2020-2031) & (US$ Million)
  • Figure 61. India Corticosteroids API Sales Value by Type (%), 2024 VS 2031
  • Figure 62. India Corticosteroids API Sales Value by Application (%), 2024 VS 2031
  • Figure 63. Corticosteroids API Industrial Chain
  • Figure 64. Corticosteroids API Manufacturing Cost Structure
  • Figure 65. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 66. Bottom-up and Top-down Approaches for This Report
  • Figure 67. Data Triangulation
  • Figure 68. Key Executives Interviewed